Market Cap 2.07B
Revenue (ttm) 605.22M
Net Income (ttm) -168.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.86%
Debt to Equity Ratio 0.27
Volume 1,012,100
Avg Vol 923,308
Day's Range N/A - N/A
Shares Out 111.49M
Stochastic %K 81%
Beta 0.65
Analysts Strong Sell
Price Target $36.28

Latest News on NVCR

NovoCure Limited (NVCR) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 10:34 AM EDT - 2 days ago

NovoCure Limited (NVCR) Q1 2025 Earnings Call Transcript


Novocure Reports First Quarter 2025 Financial Results

Apr 24, 2025, 7:00 AM EDT - 2 days ago

Novocure Reports First Quarter 2025 Financial Results


Novocure to Report First Quarter 2025 Financial Results

Apr 1, 2025, 7:00 AM EDT - 25 days ago

Novocure to Report First Quarter 2025 Financial Results


NovoCure Q4 2024 Earnings: Strong And Growing Pipeline

Feb 28, 2025, 1:10 PM EST - 2 months ago

NovoCure Q4 2024 Earnings: Strong And Growing Pipeline


Novocure to Participate in Upcoming Investor Conferences

Nov 27, 2024, 7:00 AM EST - 5 months ago

Novocure to Participate in Upcoming Investor Conferences


Novocure Appoints Christoph Brackmann as Chief Financial Officer

Oct 30, 2024, 7:02 AM EDT - 6 months ago

Novocure Appoints Christoph Brackmann as Chief Financial Officer


Novocure Reports Third Quarter 2024 Financial Results

Oct 30, 2024, 7:00 AM EDT - 6 months ago

Novocure Reports Third Quarter 2024 Financial Results


NovoCure: There Is Still More Upside

Oct 16, 2024, 11:00 AM EDT - 6 months ago

NovoCure: There Is Still More Upside


Novocure to Report Third Quarter 2024 Financial Results

Oct 1, 2024, 7:00 AM EDT - 7 months ago

Novocure to Report Third Quarter 2024 Financial Results


Novocure Announces Planned CEO Transition

Sep 3, 2024, 7:00 AM EDT - 8 months ago

Novocure Announces Planned CEO Transition


Biotech stocks: Which drugmakers are worth a buy?

Aug 12, 2024, 5:13 PM EDT - 9 months ago

Biotech stocks: Which drugmakers are worth a buy?

ARGX


NovoCure Limited: A Post Q2 Analysis

Jul 26, 2024, 12:34 PM EDT - 9 months ago

NovoCure Limited: A Post Q2 Analysis


NovoCure Limited (NVCR) Q2 2024 Earnings Call Transcript

Jul 25, 2024, 12:35 PM EDT - 9 months ago

NovoCure Limited (NVCR) Q2 2024 Earnings Call Transcript


Novocure Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 7:00 AM EDT - 9 months ago

Novocure Reports Second Quarter 2024 Financial Results


Novocure to Report Second Quarter 2024 Financial Results

Jul 1, 2024, 7:00 AM EDT - 10 months ago

Novocure to Report Second Quarter 2024 Financial Results


Novocure Reports First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 1 year ago

Novocure Reports First Quarter 2024 Financial Results


Novocure to Report First Quarter 2024 Financial Results

Apr 1, 2024, 7:00 AM EDT - 1 year ago

Novocure to Report First Quarter 2024 Financial Results


Novocure's lung cancer therapy succeeds in late-stage trial

Mar 27, 2024, 7:12 AM EDT - 1 year ago

Novocure's lung cancer therapy succeeds in late-stage trial